UNSPSC 51433906: Aprikalim

This classification denotes an antihypertensive agent with the molecular formula C12H16N2OS2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 374BH4KVRG, chemically known as 2h-thiopyran-2-carbothioamide, tetrahydro-n-methyl-2-(3-pyridinyl)-, 1-oxide but generally known as aprikalim, which bears US NIH Compound Identifier 3034038. European Medicines Agency schedules Aprikalim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05541MIG.

UNSPSC 51433906 Aprikalim, a Commodity code, represents emergency medical medications supplied to fire rescue and emergency response services for field administration during acute medical events. State and local governments procure these pharmaceuticals — in this case epinephrine, labetalol, adenosine, and diltiazem formulations — in bulk unit quantities for stockpiling and continuous replenishment by emergency services departments. The buying bodies are primarily fire departments and emergency medical services agencies operating within county and municipal jurisdictions. Vendors must meet strict regulatory and safety requirements, including OSHA-compliant Safety Data Sheets, accessibility documentation conforming to WCAG 2.2 Level AA and Section 508 standards, and product warranties guaranteeing freedom from defects for a minimum of 365 days. Suppliers are responsible for managing expiration logistics, including pickup and replacement of expired stock before product shelf life is exhausted, and must guarantee delivery within ten calendar days of order receipt with all costs absorbed in firm pricing.

The City of Tampa's Purchasing Department solicited Advanced Life Support Medications (Solicitation 26P00188) as an IFB via the OpenGov eProcurement Portal with a response deadline of April 8, 2026 and an estimated contract value of $40,000. The solicitation applied a Small Local Business Enterprise sheltered market designation offering a 5 percent bid discount capped at $10,000 for SLBE participation. The contract term ran for one year from award with two renewal options of one year each, plus unilateral extension rights for up to three additional 30-day periods. The single identified recent opportunity shows activity in Florida; beyond this posting, the source does not support characterization of geographic spread or issuing-body concentration across additional jurisdictions.